Prescribing Digital Therapeutics as the Medicine of Today
Digital therapeutic interventions have clinically demonstrated abilities and are making their way through the FDA and into the hands of consumers and patients. With the global digital therapeutics market expected to reach $11.8B. by 2027, this “software as medicine” category is continuing to grow at warp speed, treating conditions like addiction, poor sleep, diabetes, respiratory ailments, pain and much more. Join four pioneering companies for a behind-the-scenes look at the technology, strategy, challenges and future of this revolutionary new way in treating the patient.